David E. Amacher

2.8k total citations
74 papers, 2.1k citations indexed

About

David E. Amacher is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, David E. Amacher has authored 74 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Pharmacology and 21 papers in Cancer Research. Recurrent topics in David E. Amacher's work include Carcinogens and Genotoxicity Assessment (20 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Drug-Induced Hepatotoxicity and Protection (18 papers). David E. Amacher is often cited by papers focused on Carcinogens and Genotoxicity Assessment (20 papers), Pharmacogenetics and Drug Metabolism (19 papers) and Drug-Induced Hepatotoxicity and Protection (18 papers). David E. Amacher collaborates with scholars based in United States, United Kingdom and Australia. David E. Amacher's co-authors include Shelli Schomaker, Simone C. Paillet, Gail N. Turner, Michael W. Lieberman, Verne A. Ray, John E. Burkhardt, Naga Chalasani, John A. Elliott, Jiri Aubrecht and James A. Retsema and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemical and Biophysical Research Communications and Environmental Health Perspectives.

In The Last Decade

David E. Amacher

73 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Amacher United States 27 758 599 519 298 266 74 2.1k
Michael A. Pereira United States 25 759 1.0× 307 0.5× 445 0.9× 127 0.4× 290 1.1× 66 2.0k
Shelli Schomaker United States 15 481 0.6× 670 1.1× 219 0.4× 389 1.3× 233 0.9× 25 1.9k
Caroline Aninat France 19 855 1.1× 620 1.0× 291 0.6× 325 1.1× 329 1.2× 34 2.2k
Sophie Langouët France 32 1.8k 2.4× 690 1.2× 808 1.6× 251 0.8× 450 1.7× 74 3.5k
S.S. Thorgeirsson United States 21 810 1.1× 581 1.0× 455 0.9× 238 0.8× 632 2.4× 44 2.1k
Jiri Aubrecht United States 32 1.1k 1.5× 347 0.6× 801 1.5× 255 0.9× 338 1.3× 69 2.3k
A. M. Monro United States 20 503 0.7× 497 0.8× 243 0.5× 103 0.3× 207 0.8× 63 2.2k
Josef Ozer United States 18 961 1.3× 442 0.7× 150 0.3× 298 1.0× 247 0.9× 27 2.5k
Graham R. Betton United Kingdom 15 583 0.8× 501 0.8× 134 0.3× 124 0.4× 201 0.8× 34 2.2k
Fabrice Morel France 32 1.7k 2.2× 1.2k 1.9× 430 0.8× 428 1.4× 683 2.6× 51 3.6k

Countries citing papers authored by David E. Amacher

Since Specialization
Citations

This map shows the geographic impact of David E. Amacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Amacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Amacher more than expected).

Fields of papers citing papers by David E. Amacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Amacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Amacher. The network helps show where David E. Amacher may publish in the future.

Co-authorship network of co-authors of David E. Amacher

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Amacher. A scholar is included among the top collaborators of David E. Amacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Amacher. David E. Amacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aubrecht, Jiri, Shelli Schomaker, & David E. Amacher. (2013). Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury. Genome Medicine. 5(9). 85–85. 23 indexed citations
2.
Amacher, David E., Shelli Schomaker, & Jiri Aubrecht. (2013). Development of Blood Biomarkers for Drug-Induced Liver Injury: An Evaluation of Their Potential for Risk Assessment and Diagnostics. Molecular Diagnosis & Therapy. 17(6). 343–354. 43 indexed citations
3.
Amacher, David E.. (2012). The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology. 8(3). 335–347. 43 indexed citations
4.
Amacher, David E.. (2011). The mechanistic basis for the induction of hepatic steatosis by xenobiotics. Expert Opinion on Drug Metabolism & Toxicology. 7(8). 949–965. 22 indexed citations
5.
Amacher, David E.. (2010). The effects of cytochrome P450 induction by xenobiotics on endobiotic metabolism in pre-clinical safety studies. Toxicology Mechanisms and Methods. 20(4). 159–166. 38 indexed citations
6.
Amacher, David E.. (2006). Reactive Intermediates and the Pathogenesis of Adverse Drug Reactions: The Toxicology Perspective. Current Drug Metabolism. 7(3). 219–229. 21 indexed citations
7.
Tukov, F, Jane F. Maddox, David E. Amacher, et al.. (2006). Modeling inflammation–drug interactions in vitro: A rat Kupffer cell-hepatocyte coculture system. Toxicology in Vitro. 20(8). 1488–1499. 61 indexed citations
8.
Amacher, David E., et al.. (2005). The relationship among microsomal enzyme induction, liver weight, and histological change in cynomolgus monkey toxicology studies. Food and Chemical Toxicology. 44(4). 528–537. 37 indexed citations
9.
Updyke, Lawrence W., et al.. (2002). Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG1 and IgE against co-injected TNP–OVA. Toxicology Letters. 131(3). 167–180. 16 indexed citations
10.
Amacher, David E., Shelli Schomaker, & John E. Burkhardt. (2001). The relationship among microsomal enzyme induction, liver weight and histological change in beagle dog toxicology studies. Food and Chemical Toxicology. 39(8). 817–825. 17 indexed citations
11.
Amacher, David E., et al.. (1998). In vitro toxicity of zamifenacin (UK-76,654) and metabolites in primary hepatocyte cultures. Xenobiotica. 28(9). 895–908. 8 indexed citations
12.
Amacher, David E., Shelli Schomaker, & John E. Burkhardt. (1998). The Relationship Among Microsomal Enzyme Induction, Liver Weight and Histological Change in Rat Toxicology Studies. Food and Chemical Toxicology. 36(9-10). 831–839. 95 indexed citations
13.
Amacher, David E., et al.. (1997). Hepatic Microsomal Enzyme Induction, β-Oxidation, and Cell Proliferation Following Administration of Clofibrate, Gemfibrozil, or Bezafibrate in the CD Rat. Toxicology and Applied Pharmacology. 142(1). 143–150. 43 indexed citations
14.
Amacher, David E. & Shelli Schomaker. (1994). Effects of hexachlorophene on myelin marker enzymes in rat oligodendrocytes. Toxicology in Vitro. 8(1). 1–11. 1 indexed citations
15.
Amacher, David E., et al.. (1993). Preclinical toxicology studies with azithromycin: genetic toxicology evaluation. Mutation Research/Genetic Toxicology. 300(2). 79–90. 16 indexed citations
16.
Amacher, David E. & Gail N. Turner. (1989). The critical influence of temperature upon trifluorothymidine resistance in mouse lymphoma L5178Y/TK 3.7.2C cells. Mutation Research/Genetic Toxicology. 224(4). 415–426. 2 indexed citations
17.
Amacher, David E., et al.. (1987). Differences in the constitutive forms of hepatic cytochrome p-450 in male and female adult beagle dogs. Journal of Chromatography B Biomedical Sciences and Applications. 419. 61–73. 4 indexed citations
18.
Amacher, David E. & Gail N. Turner. (1987). The mutagenicity of 5-azacytidine and other inhibitors of replicative DNA synthesis in the L5178Y mouse lymphoma cell. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 176(1). 123–131. 23 indexed citations
19.
Amacher, David E. & Simone C. Paillet. (1982). Hamster hepatocyte-mediated activation of procarcinogens to mutagens in the L5178Y/TK mutation assay. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 106(2). 305–316. 7 indexed citations
20.
Amacher, David E., Adhid Al-Arif, & Samuel S. Epstein. (1974). Effects of ingested chrysotile on DNA synthesis in the gastrointestinal tract and liver of the rat. Environmental Health Perspectives. 9. 319–324. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Pereira Breakdown of academic impact, for papers by Shelli Schomaker Breakdown of academic impact, for papers by Caroline Aninat Breakdown of academic impact, for papers by Sophie Langouët Breakdown of academic impact, for papers by S.S. Thorgeirsson Breakdown of academic impact, for papers by Jiri Aubrecht Breakdown of academic impact, for papers by A. M. Monro Breakdown of academic impact, for papers by Josef Ozer Breakdown of academic impact, for papers by Graham R. Betton Breakdown of academic impact, for papers by Fabrice Morel
Rankless by CCL
2026